Physiomics plc (LSE:PYC) reported revenue of £941,222 for the year to 30 June 2026, up from £784,005, while its loss after tax widened to £697,034. The year also included a fundraise and a change of board following a requisitioned general meeting.

What was announced

Physiomics published its results for the financial year ended 30 June 2026 (FY26). Total income, including grants, rose 26.5% to £1,055,169, compared with £834,156 in FY25. Within that, revenue increased to £941,222 from £784,005.

Despite the higher income, losses increased. The operating loss was £687,254, compared with £457,791 a year earlier. The loss after tax was £697,034, against £415,254 in FY25, and the loss per share was 0.20p, compared with 0.17p.

On our calculation, revenue grew by about 20.1%, slightly slower than total income, which implies grant and other income of about £113,900 in FY26 compared with about £50,200 in FY25. Also on our calculation, the operating loss increased by about £229,500, or roughly 50%, and the loss after tax by about £281,800, or roughly 68%.

Balance sheet and funding

Cash at 30 June 2026 was £418,635, down from £461,242 a year earlier. Net assets fell to £523,977 from £692,171, a reduction of about £168,200 on our calculation.

During the year the company raised £600,000 gross through a placing and retail offer in March 2026. On our calculation, cash nonetheless fell by about £42,600 over the year, despite the fundraise.

Contracts and order book

Physiomics said it won contracts worth more than £1m in FY26, across 24 awards. Five of those awards were for its Biometrics work. At 1 July 2026, the company had contracted revenue yet to be recognised of about £618,000, which represents work already won that is expected to be booked as revenue in future periods. On our calculation, that figure is equivalent to about 66% of the revenue recognised in the whole of FY26, although the announcement does not say over what period it will be recognised.

The company has also announced further awards since the year end. These were contracts worth more than £200,000, announced on 8 July 2026, and more than £205,000, announced on 10 September 2026. On our calculation, these two post-period awards together total more than £405,000, in addition to the contracted revenue figure at 1 July. The announcement does not state over what period this work is expected to be delivered.

Board changes

FY26 included a significant change to the board. Following a requisitioned general meeting on 29 April 2026, directors Sargent, Kumar, Millen and Corn were removed from the board. Nick Tulloch became Chairman, and Ian Bagnall became Finance Director.

The board said it expects the higher costs incurred in FY26 not to recur in FY27. This is a company expectation. The details available for this article do not break down the specific costs involved or quantify how much of the increase in the operating loss is attributable to them, so this article does not estimate that figure.

What to watch next

The company's annual general meeting is scheduled for 5 November 2026. Shareholders may look for further comment there on trading in the new financial year and on the board's priorities following the changes in April.

Other points of interest set out in the results include the conversion of the roughly £618,000 of contracted revenue and the post-period awards into recognised revenue, and whether costs fall back in FY27 as the board expects. The company's cash position, at £418,635 at the year end, will also be relevant given that the business remained loss-making in FY26. The announcement does not include specific FY27 revenue or profit guidance, so none is reported here.